Therapeutic potential of Toll-like receptor 9 activation
AM Krieg - Nature reviews Drug discovery, 2006 - nature.com
In the decade since the discovery that mouse B cells respond to certain unmethylated CpG
dinucleotides in bacterial DNA, a specific receptor for these'CpG motifs' has been identified …
dinucleotides in bacterial DNA, a specific receptor for these'CpG motifs' has been identified …
Toll-like receptors in systemic autoimmune disease
A Marshak-Rothstein - Nature Reviews Immunology, 2006 - nature.com
Toll-like receptors (TLRs) have a crucial role in the early detection of pathogen-associated
molecular patterns and the subsequent activation of the adaptive immune response …
molecular patterns and the subsequent activation of the adaptive immune response …
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
SR Christensen, J Shupe, K Nickerson, M Kashgarian… - Immunity, 2006 - cell.com
Antibodies (Abs) to RNA-and DNA-containing autoantigens are characteristic of systemic
lupus erythematosus (SLE). We showed previously that Toll-like receptor (TLR) 9 …
lupus erythematosus (SLE). We showed previously that Toll-like receptor (TLR) 9 …
Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus
FJ Barrat, T Meeker, J Gregorio, JH Chan… - The Journal of …, 2005 - rupress.org
Raised serum levels of interferon (IFN)-α have been observed in systemic lupus
erythematosus (SLE) patients, and these levels are correlated with both disease activity and …
erythematosus (SLE) patients, and these levels are correlated with both disease activity and …
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
J Vollmer, AM Krieg - Advanced drug delivery reviews, 2009 - Elsevier
Toll-like receptor 9 (TLR9) agonists have demonstrated substantial potential as vaccine
adjuvants, and as mono-or combination therapies for the treatment of cancer and infectious …
adjuvants, and as mono-or combination therapies for the treatment of cancer and infectious …
The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity
MT Lotze, HJ Zeh, A Rubartelli… - Immunological …, 2007 - Wiley Online Library
The response to pathogens and damage in plants and animals involves a series of carefully
orchestrated, highly evolved, molecular mechanisms resulting in pathogen resistance and …
orchestrated, highly evolved, molecular mechanisms resulting in pathogen resistance and …
Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer
Since first being described in the fruit fly Drosophila melanogaster, Toll-like receptors (TLRs)
have proven to be of great interest to immunologists and investigators interested in the …
have proven to be of great interest to immunologists and investigators interested in the …
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
R Baccala, K Hoebe, DH Kono, B Beutler… - Nature medicine, 2007 - nature.com
We formulate a two-phase paradigm of autoimmunity associated with systemic lupus
erythematosus, the archetypal autoimmune disease. The initial Toll-like receptor (TLR) …
erythematosus, the archetypal autoimmune disease. The initial Toll-like receptor (TLR) …
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
J Vollmer, S Tluk, C Schmitz, S Hamm, M Jurk… - The Journal of …, 2005 - rupress.org
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the
production of autoantibodies to certain cellular macromolecules, such as the small nuclear …
production of autoantibodies to certain cellular macromolecules, such as the small nuclear …
Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity
AM Krieg, J Vollmer - Immunological reviews, 2007 - Wiley Online Library
Toll‐like receptors (TLRs) detect infections by highly conserved components of pathogens
that are either not present in our own cells or are normally sequestered in cellular …
that are either not present in our own cells or are normally sequestered in cellular …